. . . . . . . "[These data indicate that both n-3 and n-6 PUFAs may be beneficial in prostate cancer by altering IFN-? signaling, thus inhibiting IL-18BP production and thereby rendering prostate cancer cells more sensitive to IL-18-mediated immune responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:52+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .